Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.

    • Co-founder and CEO of 23andMe
  2. Anne Wojcicki erwarb 1996 einen Bachelor -Abschluss in Biologie von der Yale University und arbeitete dann zehn Jahre als Analystin, spezialisiert auf Biotechnologiefirmen. 2006 gründete sie mit Linda Avey und anderen die Firma für Gentests 23andMe in Mountain View. [1]

  3. Vor 2 Tagen · Anne Wojcicki (born July 28, 1973, San Mateo county, California) is an American entrepreneur and cofounder and chief executive officer of the personal genetics company 23andMe. Wojcicki received a B.S. degree (1996) in biology from Yale University. She later worked as a researcher and as an investment analyst.

  4. www.forbes.com › profile › anne-wojcickiAnne Wojcicki - Forbes

    Anne Wojcicki is the cofounder and CEO of 23andMe, a direct-to-consumer genetics testing firm that went public in 2021. She is the sister of YouTube's former CEO Susan Wojcicki and has a net worth of $270 million as of 2023.

  5. 20. Mai 2021 · Listen to Anne Wojcicki, CEO of 23andMe, a genetic testing and analysis company, talk about her vision, challenges and achievements in an emerging industry. Learn how she balances individual and public interests in using DNA data for personalized and population health.

  6. 10. Apr. 2020 · Anne Wojcicki: ‘This is the way the world is going’. As chief executive of 23andMe, she holds the key to a vast genetic database. What will she do with it? Hannah Kuchler. April 10 2020. Stay...

  7. CEO and Co-Founder. Anne co-founded 23andMe in 2006, three years after the first human genome was sequenced. Her goal was audacious: to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process.